#KO
### π’ ν•μ›μ„Έν‹°λ¦¬μ§„μ •(μ„Έν‹°λ¦¬μ§„μ—Όμ‚°μ—Ό) - ν¨λ¥ λ° ν¨κ³Ό
* μ΄ μ•½μ€ κ³„μ μ„± λ° λ‹¤λ…„μ„± μ•λ λ¥΄κΈ°μ„± λΉ„μ—Ό, μ•λ λ¥΄κΈ°μ„± κ²°λ§‰μ—Ό, λ§μ„± νΉλ°μ„± λ‘λ“λ¬κΈ°, ν”Όλ¶€κ°€λ ¤μ›€μ¦κ³ΌΒ ν•μ΄λ“λ΅μ½”ν‹°μ† μ™Έμ©μ μ™€ λ³‘μ©μ— μν• μµμ§„, ν”Όλ¶€μ—Όμ— μ‚¬μ©ν•©λ‹λ‹¤.

### π•’ ν•μ›μ„Έν‹°λ¦¬μ§„μ •(μ„Έν‹°λ¦¬μ§„μ—Όμ‚°μ—Ό) - μ©λ²• λ° μ©λ‰
* μ„±μΈ λ° 6μ„Έ μ΄μƒμ μ†μ•„λ” 1μΌ 1ν 1μ •(10 mg)μ„ μ·¨μΉ¨ μ „μ— λ³µμ©ν•κ³ , μ΄μƒλ°μ‘μ— λ―Όκ°ν• ν™μμ κ²½μ°λ”Β 1/2μ •(5 mg)μ”©μ„ μ•„μΉ¨, μ €λ…μ— λ¶„ν•  λ³µμ©ν•©λ‹λ‹¤.

μ—°λ Ή, μ¦μƒμ— λ”°λΌ μ μ ν μ¦κ°ν•©λ‹λ‹¤.

μ‹ μ¥μ•  ν™μμ ν¬μ—¬ κ°„κ²©μ€ ν™μμ μ‹ κΈ°λ¥μ— λ”°λΌ μ΅°μ λμ–΄μ•Ό ν•κ³ , μ‹ μ¥μ• λ¥Ό κ°€μ§„ μ†μ•„ ν™μλ” ν™μμ μ‹  μ²­μ†μ¨κ³Ό μ²΄μ¤‘μ„ κ³ λ ¤ν•μ—¬ κ°λ³„μ μΌλ΅ μ©λ‰μ„ μ΅°μ ν•΄μ•Ό ν•λ―€λ΅ μμ„Έν• μ‚¬ν•­μ€ ν—κ°€μ‚¬ν•­μ„ μ°Έκ³ ν•μ‹­μ‹μ¤.

### β οΈ ν•μ›μ„Έν‹°λ¦¬μ§„μ •(μ„Έν‹°λ¦¬μ§„μ—Όμ‚°μ—Ό) - μ£Όμμ‚¬ν•­
* μ •λ³΄ μ—†μ
* μ΄ μ•½ λ°Β νλ“λ΅μ‹μ§„ λλ” ν”ΌνλΌμ§„ μ λ„μ²΄μ— κ³Όλ―Όμ¦ ν™μ, μ‹ λ¶€μ „ ν™μ(ν¬λ μ•„ν‹°λ‹ μ²­μ†μ¨ 

μ΄ μ•½μ„ λ³µμ©ν•κΈ° μ „μ— μ„λ¶€, μμ λ¶€, μ‹ μ¥μ• (μ‹ μ¥μ¥μ• ), κ°„μ¥μ•  ν™μ, λ…ΈμΈ,Β κ°„μ§ λ° λ°μ‘ μ„ν—μ„±μ΄ μλ” ν™μ,Β μ†λ³€κ³ μ„μ μ„ ν–‰μ”μΈ(μ²™μ λ³‘λ³€, μ „λ¦½μ„  λΉ„λ€μ¦)μ΄ μλ” ν™μλ” μμ‚¬ λλ” μ•½μ‚¬μ™€ μƒμν•μ‹­μ‹μ¤.

#KO
### π’ ν•μ›μ„Έν‹°λ¦¬μ§„μ •(μ„Έν‹°λ¦¬μ§„μ—Όμ‚°μ—Ό) - ν¨λ¥ λ° ν¨κ³Ό
* μ΄ μ•½μ€ κ³„μ μ„± λ° λ‹¤λ…„μ„± μ•λ λ¥΄κΈ°μ„± λΉ„μ—Ό, μ•λ λ¥΄κΈ°μ„± κ²°λ§‰μ—Ό, λ§μ„± νΉλ°μ„± λ‘λ“λ¬κΈ°, ν”Όλ¶€κ°€λ ¤μ›€μ¦κ³ΌΒ ν•μ΄λ“λ΅μ½”ν‹°μ† μ™Έμ©μ μ™€ λ³‘μ©μ— μν• μµμ§„, ν”Όλ¶€μ—Όμ— μ‚¬μ©ν•©λ‹λ‹¤.

### π•’ ν•μ›μ„Έν‹°λ¦¬μ§„μ •(μ„Έν‹°λ¦¬μ§„μ—Όμ‚°μ—Ό) - μ©λ²• λ° μ©λ‰
* μ„±μΈ λ° 6μ„Έ μ΄μƒμ μ†μ•„λ” 1μΌ 1ν 1μ •(10 mg)μ„ μ·¨μΉ¨ μ „μ— λ³µμ©ν•κ³ , μ΄μƒλ°μ‘μ— λ―Όκ°ν• ν™μμ κ²½μ°λ”Β 1/2μ •(5 mg)μ”©μ„ μ•„μΉ¨, μ €λ…μ— λ¶„ν•  λ³µμ©ν•©λ‹λ‹¤.

μ—°λ Ή, μ¦μƒμ— λ”°λΌ μ μ ν μ¦κ°ν•©λ‹λ‹¤.

μ‹ μ¥μ•  ν™μμ ν¬μ—¬ κ°„κ²©μ€ ν™μμ μ‹ κΈ°λ¥μ— λ”°λΌ μ΅°μ λμ–΄μ•Ό ν•κ³ , μ‹ μ¥μ• λ¥Ό κ°€μ§„ μ†μ•„ ν™μλ” ν™μμ μ‹  μ²­μ†μ¨κ³Ό μ²΄μ¤‘μ„ κ³ λ ¤ν•μ—¬ κ°λ³„μ μΌλ΅ μ©λ‰μ„ μ΅°μ ν•΄μ•Ό ν•λ―€λ΅ μμ„Έν• μ‚¬ν•­μ€ ν—κ°€μ‚¬ν•­μ„ μ°Έκ³ ν•μ‹­μ‹μ¤.

### β οΈ ν•μ›μ„Έν‹°λ¦¬μ§„μ •(μ„Έν‹°λ¦¬μ§„μ—Όμ‚°μ—Ό) - μ£Όμμ‚¬ν•­
* μ •λ³΄ μ—†μ
* μ΄ μ•½ λ°Β νλ“λ΅μ‹μ§„ λλ” ν”ΌνλΌμ§„ μ λ„μ²΄μ— κ³Όλ―Όμ¦ ν™μ, μ‹ λ¶€μ „ ν™μ(ν¬λ μ•„ν‹°λ‹ μ²­μ†μ¨ <10mL/min [μ›λ¬Έ μ •λ³΄ λ¶μ™„μ „])
* μ΄ μ•½μ„ λ³µμ©ν•κΈ° μ „μ— μ„λ¶€, μμ λ¶€, μ‹ μ¥μ• (μ‹ μ¥μ¥μ• ), κ°„μ¥μ•  ν™μ, λ…ΈμΈ,Β κ°„μ§ λ° λ°μ‘ μ„ν—μ„±μ΄ μλ” ν™μ,Β μ†λ³€κ³ μ„μ μ„ ν–‰μ”μΈ(μ²™μ λ³‘λ³€, μ „λ¦½μ„  λΉ„λ€μ¦)μ΄ μλ” ν™μλ” μμ‚¬ λλ” μ•½μ‚¬μ™€ μƒμν•μ‹­μ‹μ¤.

#EN
### π’ ν•μ›μ„Έν‹°λ¦¬μ§„μ •(μ„Έν‹°λ¦¬μ§„μ—Όμ‚°μ—Ό) - Efficacy and Effects
*   This medicine is used for seasonal and perennial allergic rhinitis, allergic conjunctivitis, chronic idiopathic urticaria, pruritus, and, in combination with topical hydrocortisone, for eczema and dermatitis.

### π•’ ν•μ›μ„Έν‹°λ¦¬μ§„μ •(μ„Έν‹°λ¦¬μ§„μ—Όμ‚°μ—Ό) - Dosage and Administration
*   Adults and children aged 6 years and older should take 1 tablet (10 mg) once daily at bedtime. For patients sensitive to adverse reactions, 1/2 tablet (5 mg) should be taken divided into morning and evening doses.

The dosage may be appropriately increased or decreased depending on age and symptoms.

The dosing interval for patients with renal impairment should be adjusted according to the patient's renal function. For pediatric patients with renal impairment, the dosage should be individually adjusted considering the patient's renal clearance and body weight. Please refer to the approved product information for detailed instructions.

### β οΈ ν•μ›μ„Έν‹°λ¦¬μ§„μ •(μ„Έν‹°λ¦¬μ§„μ—Όμ‚°μ—Ό) - Precautions
*   No information provided.
*   Patients with hypersensitivity to this medicine, hydroxyzine, or piperazine derivatives, patients with renal failure (creatinine clearance <10mL/min [original text indicates truncated information]).
*   Before taking this medicine, pregnant women, breastfeeding women, patients with renal impairment, hepatic impairment, the elderly, patients with epilepsy and a risk of convulsions, and patients with predisposing factors for urine retention (spinal cord lesion, benign prostatic hyperplasia) should consult a doctor or pharmacist.

#CN
### π’ ν•μ›μ„Έν‹°λ¦¬μ§„μ •(μ„Έν‹°λ¦¬μ§„μ—Όμ‚°μ—Ό) - εζ•εζ•ζ
*   ζ¬θ―η”¨δΊε­£θ‚ζ€§εεΈΈεΉ΄ζ€§θΏ‡ζ•ζ€§ιΌ»η‚γ€θΏ‡ζ•ζ€§η»“θ†η‚γ€ζ…Άζ€§η‰Ήε‘ζ€§θ¨ιΊ»η–Ήγ€η®θ‚¤η™η—’οΌδ»¥εδΈζ°Άε–ε―η„ζΎε¤–η”¨ε¶ε‰‚θ”εη”¨δΊζΉΏη–Ήγ€η®η‚γ€‚

### π•’ ν•μ›μ„Έν‹°λ¦¬μ§„μ •(μ„Έν‹°λ¦¬μ§„μ—Όμ‚°μ—Ό) - η”¨ζ³•εη”¨ι‡
*   ζδΊΊε6ε²δ»¥δΈε„Ώη«¥οΌζ―ζ—¥δΈ€ζ¬΅οΌη΅ε‰ζη”¨1η‰‡οΌ10ζ―«ε…‹οΌ‰γ€‚ε―ΉδΊε―ΉδΈθ‰―εεΊ”ζ•ζ„η„ζ‚£θ€…οΌε―ε°†1/2η‰‡οΌ5ζ―«ε…‹οΌ‰ε†δΈΊζ—©ζ™δΈ¤ζ¬΅ζη”¨γ€‚

ζ Ήζ®εΉ΄ιΎ„γ€η—‡η¶ι€‚ε½“εΆε‡ε‰‚ι‡γ€‚

θ‚Ύεθƒ½δΈε…¨ζ‚£θ€…η„η»™θ―ι—΄ι”εΊ”ζ Ήζ®ζ‚£θ€…η„θ‚Ύεθƒ½θΏ›θ΅θ°ƒζ•΄οΌ›ε―ΉδΊζ‚£ζ‰θ‚Ύεθƒ½δΈε…¨η„ε„Ώη«¥ζ‚£θ€…οΌεΊ”ζ Ήζ®ζ‚£θ€…η„θ‚ΎζΈ…ι™¤η‡ε’δ½“ι‡ε•η‹¬θ°ƒζ•΄ε‰‚ι‡οΌε› ζ­¤θ―¦η»†δΏ΅ζ―θ―·ε‚θ€ƒδΊ§ε“θ―΄ζδΉ¦γ€‚

### β οΈ ν•μ›μ„Έν‹°λ¦¬μ§„μ •(μ„Έν‹°λ¦¬μ§„μ—Όμ‚°μ—Ό) - ζ³¨ζ„δΊ‹ι΅Ή
*   ζ— δΏ΅ζ―γ€‚
*   ε―Ήζ¬θ―γ€ηΎε—ζ–ε“ε—θ΅η”η‰©θΏ‡ζ•η„ζ‚£θ€…οΌθ‚Ύθ΅°η«­ζ‚£θ€…οΌθ‚ι…ζΈ…ι™¤η‡ <10mL/min [εζ–‡δΏ΅ζ―δΈε®ζ•΄]οΌ‰γ€‚
*   ζη”¨ζ¬θ―ε‰οΌε­•ε¦‡γ€ε“ΊδΉ³ζε¦‡ε¥³γ€θ‚Ύεθƒ½δΈε…¨ζ‚£θ€…γ€θ‚εθƒ½δΈε…¨ζ‚£θ€…γ€θ€εΉ΄δΊΊγ€η™«η—«εζ‰η™«η—«ε‘δ½ι£ι™©η„ζ‚£θ€…γ€ζ‰ε°Ώζ½΄η•™θ―±ε› οΌθ„ι«“η—…εγ€ε‰ε—θ…Ίθ‚¥ε¤§οΌ‰η„ζ‚£θ€…εΊ”ε’¨θ―Άε»η”ζ–θ―εΈγ€‚

#JP
### π’ ν•μ›μ„Έν‹°λ¦¬μ§„μ •(μ„Έν‹°λ¦¬μ§„μ—Όμ‚°μ—Ό) - εΉθƒ½γƒ»εΉζ
*   γ“γ®θ–¬γ―γ€ε­£η―€ζ€§γγ‚γ³ι€εΉ΄ζ€§γ‚Άγƒ¬γƒ«γ‚®γƒΌζ€§ιΌ»η‚γ€γ‚Άγƒ¬γƒ«γ‚®γƒΌζ€§ηµθ†η‚γ€ζ…Άζ€§η‰Ήη™Ίζ€§θ•ιΊ»η–Ήγ€η®θ†γγ†η—’η—‡γ«γ€γΎγγƒ’γƒ‰γƒ­γ‚³γƒ«γƒγ‚Ύγƒ³ε¤–η”¨ε‰¤γ¨γ®δ½µη”¨γ«γ‚γ‚ζΉΏη–Ήγ€η®θ†η‚γ«η”¨γ„γ‚‰γ‚γΎγ™γ€‚

### π•’ ν•μ›μ„Έν‹°λ¦¬μ§„μ •(μ„Έν‹°λ¦¬μ§„μ—Όμ‚°μ—Ό) - η”¨ζ³•γƒ»η”¨ι‡
*   ζδΊΊγγ‚γ³6ζ­³δ»¥δΈγ®ε°ε…γ―γ€1ζ—¥1ε›1ι οΌ10mgοΌ‰γ‚’ε°±ε―ε‰γ«ζη”¨γ—γ€ε‰―δ½η”¨γ«ζ•ζ„γζ‚£θ€…γ®ε ΄εγ―γ€1/2ι οΌ5mgοΌ‰γ‚’ζγ¨ε¤•γ«ε†ε‰²γ—γ¦ζη”¨γ—γΎγ™γ€‚

εΉ΄ι½Άγ€η—‡η¶γ«εΏγγ¦ι©ε®εΆ—ζΈ›γ—γΎγ™γ€‚

θ…ζ©θƒ½ιε®³ζ‚£θ€…γ®ζ•δΈι–“ι”γ―ζ‚£θ€…γ®θ…ζ©θƒ½γ«εΏγγ¦θΏζ•΄γ™γ‚‹εΏ…θ¦γγ‚γ‚γ€θ…ζ©θƒ½ιε®³γ‚’ζγ¤ε°ε…ζ‚£θ€…γ―ζ‚£θ€…γ®θ…γ‚―γƒγ‚Άγƒ©γƒ³γ‚Ήγ¨δ½“ι‡γ‚’θ€ƒζ…®γ—γ¦ε€‹ε¥γ«η”¨ι‡γ‚’θΏζ•΄γ™γ‚‹εΏ…θ¦γγ‚γ‚‹γγ‚γ€θ©³η΄°γ«γ¤γ„γ¦γ―ζ·»δ»ζ–‡ζ›Έγ‚’ε‚η…§γ—γ¦γγ γ•γ„γ€‚

### β οΈ ν•μ›μ„Έν‹°λ¦¬μ§„μ •(μ„Έν‹°λ¦¬μ§„μ—Όμ‚°μ—Ό) - ζ³¨ζ„δΊ‹ι …
*   ζƒ…ε ±γγ—γ€‚
*   ζ¬ε‰¤γ€γƒ’γƒ‰γƒ­γ‚­γ‚·γ‚Έγƒ³γΎγγ―γƒ”γƒγƒ©γ‚Έγƒ³θε°δ½“γ«ε―Ύγ—ιζ•η—‡γ®γ‚γ‚‹ζ‚£θ€…γ€θ…δΈε…¨ζ‚£θ€…οΌγ‚―γƒ¬γ‚Άγƒγƒ‹γƒ³γ‚―γƒγ‚Άγƒ©γƒ³γ‚Ή <10mL/min [εζ–‡ζƒ…ε ±δΈε®ε…¨]οΌ‰γ€‚
*   ζ¬ε‰¤γ‚’ζη”¨γ™γ‚‹ε‰γ«γ€ε¦ε©¦γ€ζδΉ³ε©¦γ€θ…ζ©θƒ½ιε®³οΌθ…θ‡“ιε®³οΌ‰γ€θ‚ζ©θƒ½ιε®³ζ‚£θ€…γ€ι«ι½Άθ€…γ€γ¦γ‚“γ‹γ‚“γγ‚γ³γ‘γ„γ‚γ‚“γ®γƒγ‚Ήγ‚―γγ‚γ‚‹ζ‚£θ€…γ€ε°Ώι–‰γ®η΄ ε› οΌθ„ι«„η—…ε¤‰γ€ε‰η«‹θ…Ίθ‚¥ε¤§η—‡οΌ‰γγ‚γ‚‹ζ‚£θ€…γ―γ€ε»εΈ«γΎγγ―θ–¬ε‰¤εΈ«γ«γ”η›Έθ«‡γγ γ•γ„γ€‚